Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Gabelli Funds LLC

Gabelli Funds LLC lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 357,736 shares of the company’s stock after selling 6,900 shares during the period. Gabelli Funds LLC owned approximately 0.28% of Henry Schein worth $22,931,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Summit Securities Group LLC purchased a new stake in Henry Schein in the 2nd quarter valued at about $31,000. Beach Investment Counsel Inc. PA purchased a new stake in shares of Henry Schein in the 2nd quarter valued at approximately $37,000. Blue Trust Inc. raised its stake in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares during the period. Mather Group LLC. lifted its holdings in shares of Henry Schein by 16.8% in the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after acquiring an additional 216 shares during the last quarter. Finally, Palisade Asset Management LLC purchased a new position in shares of Henry Schein during the 1st quarter worth approximately $113,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

HSIC has been the topic of a number of research analyst reports. Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. cut their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Evercore ISI dropped their target price on Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 7th. Finally, UBS Group cut their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Henry Schein currently has an average rating of “Hold” and a consensus target price of $77.10.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $71.15 on Monday. The business has a 50-day simple moving average of $69.89 and a 200-day simple moving average of $70.31. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The company has a market cap of $9.11 billion, a PE ratio of 24.04, a P/E/G ratio of 1.88 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same quarter in the previous year, the business posted $1.31 EPS. The firm’s revenue was up .0% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.75 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.